Search Within

Filemon Dela Cruz

Formats
  1. Meeting Abstract (31)
  2. Journal Article (28)
  3. Editorial (2)
  4. Review (1)
Groups
  1. Pediatrics, Department of (62)
  2. Sarcoma Service (Pediatrics) (62)
  3. Center for Hematologic Malignancies (45)
  4. Tow Center for Developmental Oncology (TCDO) (43)
  5. Executive Committee, Center for Hematologic Malignancies (41)
  6. Stem Cell Transplantation and Cellular Therapy Service (41)

More Groups

People
  1. Andrew Kung (41)
  2. Daoqi You (16)
  3. Julia Glade Bender (16)
  4. Michael Ortiz (14)
  5. Emily Slotkin (13)
  6. Glorymar Ibanez Sanchez (12)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (10)
  3. Pediatric Blood and Cancer (8)
  4. Cancer Discovery (3)
  5. Nature Communications (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (12)
  3. Wiley Periodicals, Inc (8)
  4. Nature Publishing Group (7)
  5. Elsevier Inc. (3)
  6. Nature Research (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor
    Journal Article

    Woods, A. D.; Berlow, N. E.; Ortiz, M. V.; Dela Cruz, F.; Siddiquee, A.; Coutinho, D. F.; Purohit, R.; Tranbarger Freier, K. E.; Michalek, J. E.; Lathara, M.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Feasibility and clinical utility of cancer whole genome and transcriptome sequencing for pediatric and young adult solid tumors
    Meeting Abstract

    Shukla, N.; Levine, M.; Gundem, G.; Spitzer, B.; Gutierrez-Abril, J.; Bouvier, N.; Arango Ossa, J. E.; Medina-Martinez, J.; Stockfisch, E.; O'Donohue, T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Translational strategies for repotrectinib in neuroblastoma
    Journal Article

    O'Donohue, T. J.; Ibáñez, G.; Coutinho, D. F.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; You, D.; Long, M.; more...
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of desmoplastic small round cell tumor
    Journal Article

    Slotkin, E. K.; Bowman, A. S.; Levine, M. F.; Dela Cruz, F.; Coutinho, D. F.; Sanchez, G. I.; Rosales, N.; Modak, S.; Tap, W. D.; Gounder, M. M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
    Journal Article

    Adane, B.; Alexe, G.; Seong, B. K. A.; Lu, D.; Hwang, E. E.; Hnisz, D.; Lareau, C. A.; Ross, L.; Lin, S.; Dela Cruz, F. S.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • ETV6-FLT3–positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: An entity distinct from JMML
    Journal Article

    Spitzer, B.; Dela Cruz, F. S.; Ibanez Sanchez, G. D.; Zhang, Y.; Xiao, W.; Benayed, R.; Markova, A.; Rodriguez-Sanchez, M. I.; Bouvier, N.; Roshal, M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • A multicenter, open-label, randomized phase II study to compare the efficacy and safety of lenvatinib in combination with ifosfamide and etoposide versus ifosfamide and etoposide in children, adolescents, and young adults with relapsed or refractory osteosarcoma (OLIE; ITCC-082)
    Meeting Abstract

    Gaspar, N.; Campbell-Hewson, Q.; Bielack, S. S.; Campbell, M.; Bautista, F.; Meazza, C.; Janeway, K.; Dela Cruz, F. S.; Whittle, S.; Morgenstern, D. A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • A phase 1/2 study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors
    Meeting Abstract

    Dela Cruz, F.; Fox, E.; Muscal, J.; Kirov, I.; Geller, J.; Dubois, S.; Kim, A.; Croop, J.; Laetsch, T.; Minard, C.; more...
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • TPX-0005 (Repotrectinib), a next-generation ALK/ROS1/NTRK1-3 inhibitor, has potent antiproliferative and anti-tumor activity as monotherapy and in combination with chemotherapy in neuroblastoma cell lines and pediatric patient derived xenograft models
    Meeting Abstract

    O'Donohue, T.; Ibáñez, G.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; Roberts, S.; Dela Cruz, F.; Kung, A.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save